Business Context and Reporting Period
This Form 8-K Current Report was filed by Colgate-Palmolive Company on February 25, 2010. The report details corporate governance changes approved by the Board of Directors during a meeting held on the same date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the composition of the Board of Directors:
- New Appointments: Dr. Helene D. Gayle and Mr. Joseph Jimenez were elected to the Board of Directors, effective March 1, 2010.
- Departure: Mrs. Jill K. Conway will not stand for reelection at the Annual Meeting of Stockholders on May 7, 2010, as she intends to retire at the end of her current term.
Management Commentary and Risks
Management highlighted the specific expertise the new directors bring to the company:
- Dr. Helene D. Gayle: President and CEO of CARE USA, bringing expertise in global public health and hygiene, relevant to Colgate's product markets.
- Mr. Joseph Jimenez: CEO of Novartis AG, bringing extensive leadership experience in the consumer products and pharmaceutical industries.
No specific risks, contingencies, or unusual items were disclosed in this filing.
Key Facts for Investor Verification
- Confirm the effective date of the new board members (March 1, 2010).
- Verify the retirement timeline for Mrs. Jill K. Conway (end of current term, with the next election scheduled for May 7, 2010).
- Review the professional backgrounds of the new directors to assess their strategic fit with Colgate's global operations.